Literature DB >> 12065471

Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes.

Anne Sarén1, Steve Pascolo, Stefan Stevanovic, Tilman Dumrese, Mirja Puolakkainen, Matti Sarvas, Hans-Georg Rammensee, Jenni M Vuola.   

Abstract

Chlamydia pneumoniae is a common intracellular human pathogen that has been associated with several severe pathological conditions, including coronary heart disease and atherosclerosis. There is no vaccine against C. pneumoniae infection, but CD8(+) T cells have been shown to be crucial for protection during experimental infection. However, the effector functions and epitope specificity of the protective CD8(+) T cell remain unknown. The aim of this study was to identify C. pneumoniae-derived mouse CD8 epitopes by using a recent epitope prediction method. Of four C. pneumoniae proteins (the major outer membrane protein, outer membrane protein 2, polymorphic outer membrane protein 5, and heat shock protein 60), 53 potential CD8(+) T-cell epitopes were predicted by H-2 class I binding algorithms. Nineteen of the 53 peptides were identified as CD8 epitopes by testing for induction of a cytotoxic response after immunization. To test whether the predicted epitopes are naturally processed and presented by C. pneumoniae-infected cells, we generated a panel of seven peptide-specific cytotoxic T lymphocyte lines that were subsequently tested for recognition of C. pneumoniae-infected target cells. By using this strategy, we were able to identify three C. pneumoniae CD8 epitopes that were, indeed, processed and presented on infected cells. Identification of these natural CD8 epitopes provides tools for characterization of CD8(+) T-cell function in vivo and generation of epitope-specific prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065471      PMCID: PMC128055          DOI: 10.1128/IAI.70.7.3336-3343.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

Review 2.  Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

3.  Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.

Authors:  J M Vuola; V Puurula; M Anttila; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Protective DNA immunization against Chlamydia pneumoniae.

Authors:  C Svanholm; L Bandholtz; E Castaños-Velez; H Wigzell; M E Rottenberg
Journal:  Scand J Immunol       Date:  2000-04       Impact factor: 3.487

5.  Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.

Authors:  G Y Ishioka; J Fikes; G Hermanson; B Livingston; C Crimi; M Qin; M F del Guercio; C Oseroff; C Dahlberg; J Alexander; R W Chesnut; A Sette
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

6.  Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice.

Authors:  J M Penttilä; M Anttila; K Varkila; M Puolakkainen; M Sarvas; P H Mäkelä; N Rautonen
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

7.  Comparative genomes of Chlamydia pneumoniae and C. trachomatis.

Authors:  S Kalman; W Mitchell; R Marathe; C Lammel; J Fan; R W Hyman; L Olinger; J Grimwood; R W Davis; R S Stephens
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

8.  Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection.

Authors:  Y Geng; K Berencsi; Z Gyulai; T Valyi-Nagy; E Gonczol; G Trinchieri
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice.

Authors:  M E Rottenberg; A C Gigliotti Rothfuchs; D Gigliotti; C Svanholm; L Bandholtz; H Wigzell
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

10.  Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1.

Authors:  G Zhong; T Fan; L Liu
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

View more
  9 in total

1.  A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans.

Authors:  Manli Qi; Siqi Gong; Lei Lei; Quanzhong Liu; Guangming Zhong
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

2.  Chlamydia trachomatis outer membrane complex protein B (OmcB) is processed by the protease CPAF.

Authors:  Shuping Hou; Lei Lei; Zhangsheng Yang; Manli Qi; Quanzhong Liu; Guangming Zhong
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

Review 3.  Role of CD8(+)T cells in the host response to Chlamydia.

Authors:  Benjamin Wizel; Johanna Nyström-Asklin; Claudio Cortes; Amy Tvinnereim
Journal:  Microbes Infect       Date:  2008-08-26       Impact factor: 2.700

4.  Host-Cell Survival and Death During Chlamydia Infection.

Authors:  Songmin Ying; Matthew Pettengill; David M Ojcius; Georg Häcker
Journal:  Curr Immunol Rev       Date:  2007

5.  Identification of CD8 T-lymphocyte epitopes in OmpB of Rickettsia conorii.

Authors:  Zhen Li; C Marcela Díaz-Montero; Gustavo Valbuena; Xue-Jie Yu; Juan P Olano; Hui-Min Feng; David H Walker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

6.  Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) models.

Authors:  Wen Liu; Xiangshan Meng; Qiqi Xu; Darren R Flower; Tongbin Li
Journal:  BMC Bioinformatics       Date:  2006-03-31       Impact factor: 3.169

7.  Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.

Authors:  Heiner Appel; Wolfgang Kuon; Maren Kuhne; Peihua Wu; Stefanie Kuhlmann; Simon Kollnberger; Andreas Thiel; Paul Bowness; Joachim Sieper
Journal:  Arthritis Res Ther       Date:  2004-09-23       Impact factor: 5.156

8.  Transcriptional analysis of in vitro expression patterns of Chlamydophila abortus polymorphic outer membrane proteins during the chlamydial developmental cycle.

Authors:  Nicholas Wheelhouse; Kevin Aitchison; Lucy Spalding; Morag Livingstone; David Longbottom
Journal:  Vet Res       Date:  2009-05-21       Impact factor: 3.683

9.  Immunogenicity of MHC Class I Peptides Derived from Leishmania mexicana Gp63 in HLA-A2.1 Transgenic (HHDII) and BALB/C Mouse Models.

Authors:  H Rezvan; R Rees; Sa Ali
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.